HUSSMAN STRATEGIC ADVISORS, INC. – Supernus Pharmaceuticals, Inc. Transaction History
HUSSMAN STRATEGIC ADVISORS, INC. portfolio value:
$4.19M
portfolio value
HUSSMAN STRATEGIC ADVISORS, INC. quarter portfolio value change:
+17.05%
quarter
Supernus Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -4.62% | -6K shares | 437K | $33.85 | 124K |
| Q2 2022 | share | Increase | +25.00% | 26K shares | 399K | $28.92 | 130K |
| Q1 2022 | share | 0.00% | 0 shares | 328K | $32.32 | 104K | |
| Q4 2021 | share | Increase | +11.83% | 11K shares | 553K | $30.03 | 104K |
| Q3 2021 | share | 0.00% | 0 shares | -383K | $26.67 | 93K | |
| Q2 2021 | share | Decrease | -35.42% | -51K shares | -907K | $30.79 | 93K |
| Q1 2021 | share | Increase | +182.35% | 93K shares | 2.48M | $26.18 | 144K |
| Q4 2020 | share | Increase | +240.00% | 36K shares | 970K | $25.16 | 51K |
| Q3 2020 | share | 0.00% | 0 shares | -43K | $20.84 | 15K | |
| Q2 2020 | share | 0.00% | 0 shares | 86K | $23.75 | 15K | |
| Q1 2020 | share | 0.00% | 0 shares | -86K | $17.99 | 15K | |
| Q4 2019 | share | Decrease | -40.00% | -10K shares | -331K | $23.72 | 15K |
| Q3 2019 | share | 0.00% | 0 shares | -140K | $27.48 | 25K | |
| Q2 2019 | share | Decrease | -37.50% | -15K shares | -575K | $33.09 | 25K |
| Q1 2019 | share | Decrease | -38.46% | -25K shares | -757K | $35.04 | 40K |
| Q4 2018 | share | Increase | +30.00% | 15K shares | -359K | $33.22 | 65K |
| Q3 2018 | share | 0.00% | 0 shares | -474K | $50.35 | 50K | |
| Q2 2018 | share | 0.00% | 0 shares | 702K | $59.85 | 50K | |
| Q1 2018 | share | Increase | 0.00% | 50K shares | 2.29M | $45.8 | 50K |